Description
About The Author
Prof. (Dr.) Bhaswat S. Chakraborty graduated with a B.Pharm. (Hons.) from IIT, BHU and a PhD in Pharmacology from University of Saskatchewan, Canada. He is a former Professor Emeritus of Ganpat University and Nirma University, India. Before this, Dr. Chakraborty was Senior VP & Chair of R&D of Cadila Pharma, India and President of Foresee Consultants, Toronto, Canada. Prior to that he was Director of Biopharmaceutics at Biovail International, Canada and a Senior Regulator at Health Canada, Government of Canada.
Dr. Chakraborty has served as the Chairman, Pharma and Healthcare Panel, CII; and Senior Regulatory Advisor, New Drugs, Dabur Research Foundation, India. He has also had various honorary important academic, industry & government positions in Canada and USA. He has led 2 of the largest clinical trials coming out of India, trials of 2 international blockbuster drugs and 3 new drugs in India. Recipient of many honors and grants, Prof. Chakraborty has 126 scientific papers (68 full length articles and 48 abstracts) in refereed international journals and has led and reviewed >1200 projects of bioequivalence and clinical trials. Dr. Chakraborty also supervised 24 Masters and 5 PhD students; examined 58 MPharm/ MSc/ MPhil and 1 PhD theses has also many publications and interviews in non-refereed journals.






Reviews
There are no reviews yet.